Prediction of Retroperitoneal Histology in Metastatic Nonseminomatous Testicular Cancer Patients after Chemotherapy Based on Clinical and Radiological Parameters

Publisher： Karger

E-ISSN： 1661-7657|4|3|142-151

ISSN： 1661-7649

Source： Current Urology, Vol.4, Iss.3, 2010-09, pp. : 142-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Orchidectomy after Primary Chemotherapy for Metastatic Testicular Cancer

By  

Urologia Internationalis, Vol. 91, Iss. 4, 2013-09 ,pp. : 439-444

Karger

Access to resources Recommend Favorite

Current Trends in Chemotherapy for Metastatic Nonseminomatous Testicular Germ Cell Tumors

By  

Oncology, Vol. 55, Iss. 3, 1998-04 ,pp. : 177-188

Karger

Access to resources Recommend Favorite

MET amplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 675-682

John Wiley & Sons Inc

Access to resources Recommend Favorite

Surveillance Results of Patients with Stage I Nonseminomatous Germ Cell Testicular Cancer

By  

Oncology Research and Treatment, Vol. 34, Iss. 4, 2011-03 ,pp. : 173-176

Karger

Access to resources Recommend Favorite

First-Line High-Dose Chemotherapy for ’Poor Risk’ Metastatic Non-Seminomatous Testicular Germ Cell Tumors

By  

Oncology Research and Treatment, Vol. 21, Iss. 2, 1998-06 ,pp. : 23-25

Karger

Access to resources Recommend Favorite